期刊文献+

血清降钙素水平的监测对指导抗菌药物治疗肺部感染患者临床应用的价值分析 被引量:3

Clinical Value of Serum Calcitonin Monitoring in Antibiotic Therapy of Pulmonary Infection
下载PDF
导出
摘要 目的:探究血清降钙素(procalcitonin,PCT)水平的监测对指导抗菌药物治疗肺部感染患者的临床应用价值。方法:选取2017年1 1月-2018年11月间收治的肺部感染患者72例资料,按治疗方法和PCT检测结果将其随机分为对照组患者和观察组患者,每组36例;对照组患者给予抗菌药物常规治疗,观察组患者在PCT水平监测指导下给予抗菌药物治疗;比较两组患者抗菌药物使用时间和总有效率的差异,以及CRP、WBC水平的变化情况。结果:观察组患者抗菌药物治疗时间和住院时间均短于对照组(P<0.05),抗菌药物治疗费用和总费用均低于对照组(P<0.05),总有效率高于对照组(P<0.05);两组患者CRP与WBC水平值经组间比较其差异均无统计学意义(P>0.05)。结论:针对肺部感染患者,监测PCT水平以指导临床抗菌药物的使用,可缩短抗菌药物治疗时间,促进了患者的康复。 Objective: To explore the clinical application value of serum procalcitonin(PCT) level monitoring in guiding the antibiotics treatment in patients with pulmonary infection. Methods: Data of 72 patients with pulmonary infection admitted from January 2017 to November 2018 were selected. According to the treatment method and PCT test results, the patients were randomly divided into control group and observation group, with 36 patients in each group. Patients in the control group were given routine treatment with antimicrobial agents, and patients in the observation group were given antimicrobial agents under the guidance of PCT level monitoring. To compare the difference between the two groups in the duration of antimicrobial use and the total effective rate, as well as the changes in CRP and WBC levels. Results: The treatment time and hospitalization time of the observation group were shorter than those of the control group(P<0.05). The cost of antibacterial treatment and the total cost were lower than those of the control group(P<0.05). The total effective rate was higher than that of the control group(P<0.05). There was no significant difference in CRP and WBC levels between the two groups(P>0.05). Conclusion: For patients with pulmonary infection, monitoring the PCT level to guide the use of clinical antibiotics can shorten the treatment time of antibiotics and promote the recovery of patients.
作者 俞大雁 杨柳 张艳丽 YU Da-yan;YAN Liu;ZHANG Yan-li(Clinical Medical Examination and Diagnosis Center,Ningxia People's Hospital Affiliated to Ningxia MedicalUniversity,Yinchuan 750021,China;institute of Basic Sciences,Ningxia Medical University,Yinchuan 750021,China)
出处 《抗感染药学》 2019年第5期826-829,共4页 Anti-infection Pharmacy
关键词 肺部感染 PCT 抗菌药物 lung infection PCT antibiotics
  • 相关文献

二级参考文献92

  • 1抗菌药物临床应用指导原则(第一、第二部分)[J].药物不良反应杂志,2005,7(1):41-47. 被引量:60
  • 2张斗星,沈继龙.弓形虫病实验诊断方法应用进展[J].热带病与寄生虫学,2010,8(2):119-123. 被引量:4
  • 3刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:784
  • 4许炽熛.寄生虫病实验诊断的进展[J].中华检验医学杂志,2006,29(7):665-668. 被引量:9
  • 5社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 6中华医学会呼吸病学分会慢性阻塞性肺病学组.慢性阻塞性肺病诊治指南(2007年修订版).中华结核和呼吸杂志,2007,:7-16.
  • 7VESTBO J, HURD SS, AGUST? AG, et al. Global strategy for the diagnosis, management,and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Respir Crit Care Med, 2013, 187(4): 347-365.
  • 8SANDHU SK, CHU J, YURKOVICH M, et al. Variations in the management of acute exacerbations of chronic obstructive pul- monary disease[J]. Can Respir J, 2013, 20(3): 175-179.
  • 9SCHUETZ P, ALBRICH W, MUELLER B, et al. Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future[J]. BMC Med, 2011, 9: 107.
  • 10ZIELINSKA-BORKOWSKA U, SKIRECKI T, ZOTOROWICZ M, et al. Procalcitonin in early onset ventilator-associated pneumonia [J]. J Hosp Infect, 2012, 81(2): 92-97.

共引文献2197

同被引文献32

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部